Above Food Ingredients
Seed-to-fork supplier of plant proteins, specialty ingredients, and branded foods.
Something off on this page? Send us feedback.
Profile
Above Food Ingredients is a Canadian regenerative ingredient company listed on Nasdaq. It sources and processes grains and plant proteins for business customers while also selling branded and private-label consumer foods.
Above Food Ingredients Inc. is a Regina, Saskatchewan-based food company built around a vertically integrated seed-to-fork supply chain. Its main commercial work is split between disruptive agriculture and rudimentary ingredients, where it originates, grades, processes, and sells regeneratively grown grains and bespoke ingredients, and consumer packaged goods, where it develops owned brands and private-label products.
The company's ingredient centre supports cleaning, colour sorting, milling, blending, testing, and packaging for grains and pulses, while its brand portfolio includes Farmer Direct Organic, Culcherd, New Ocean, and NorQuin. Above Food became public through a business combination with Bite Acquisition Corp. and trades on Nasdaq under ABVE. Key dependencies include reliable crop origination, plant throughput, working capital availability, and demand from ingredient buyers, retailers, and private-label customers.
Company facts
Key statistics
Year to date −98.4% · Average volume (30d) 132.6K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Fiscal year | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| 2023 | — | −$2.88 | — | — | $94.7M | — |
| 2022 | — | −$0.42 | — | — | $123.7M | — |
Financial highlights
| 12 quarters | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $68.1M | $0 | $32.4M | |
| Gross profit | $0 | $0 | $0 | −$3.1M | $0 | −$1.6M | |
| Operating income | −$888.7K | −$1.1M | −$481.2K | −$12.3M | −$556.9K | −$11.7M | |
| Net income | −$727.9K | −$534.1K | $89.2K | −$16.3M | −$23.5K | −$13.1M | |
| Diluted EPS | −$0.08 | −$0.06 | $0.01 | −$1.94 | −$0.00 | −$1.26 | |
| Gross margin | — | — | — | -4.5% | — | -4.9% | |
| Operating margin | — | — | — | -18.0% | — | -36.0% |
Fiscal years (4-quarter sums)FY22 $89.0M · FY23 $68.1M
Balance sheet, Jul 31, 2024Cash & short-term investments $478.0K · Total debt $96.3M · Total assets $80.8M · Shareholders' equity −$82.9M
Dividends
No dividends on record.
Ownership
Shares outstanding 51.19M · Float 42.81M · 83.6% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Arcadia Biosciences, Inc. | 2.74M | 5.08% | 13G | Aug 19, 2025 |
| Renaissance Technologies LLC | 832.7K | 1.63% | 13F | May 14, 2026 |
| Morgan Stanley | 501.1K | 0.98% | 13F | May 15, 2026 |
| HRT Financial LP | 295.7K | 0.58% | 13F | May 14, 2026 |
| UBS Group AG | 156.8K | 0.31% | 13F | May 5, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
Not reported.


